Skip to main content
. 2017 Apr 27;7(7):1928–1939. doi: 10.7150/thno.18719

Figure 3.

Figure 3

Biodistribution of 177Lu-labeled CTT1401 (A) and CTT1403 (B) in in key PSMA+ (tumor, kidneys) and non-target tissues (blood, muscle) at 1, 4, 24, 28 and 72 h showing uptake and clearance. Data are presented as % injected dose per gram of tissue (n=5 per group, except n=10 for CTT1403 72 h group; mean +/- sd).